Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review
Ellis, P M, Coakley, N, Feld, R, Kuruvilla, S, Ung, Y C
Published in Current oncology (Toronto) (01.06.2015)
Published in Current oncology (Toronto) (01.06.2015)
Get full text
Journal Article
Communicating prognosis in cancer care: a systematic review of the literature
Hagerty, R. G., Butow, P. N., Ellis, P. M., Dimitry, S., Tattersall, M. H. N.
Published in Annals of oncology (01.07.2005)
Published in Annals of oncology (01.07.2005)
Get full text
Journal Article
Randomised, double-blind trial of carboplatin and paclitaxel with daily oral cediranib or placebo in patients with advanced non-small cell lung cancer: NCIC Clinical Trials Group study BR29
Laurie, S.A, Solomon, B.J, Seymour, L, Ellis, P.M, Goss, G.D, Shepherd, F.A, Boyer, M.J, Arnold, A.M, Clingan, P, Laberge, F, Fenton, D, Hirsh, V, Zukin, M, Stockler, M.R, Lee, C.W, Chen, E.X, Montenegro, A, Ding, K, Bradbury, P.A
Published in European journal of cancer (1990) (01.03.2014)
Published in European journal of cancer (1990) (01.03.2014)
Get full text
Journal Article
Survival in Patients With Brain Metastases From Non-Small Cell Lung Cancer Treated in the Radiosurgery Era
Swaminath, A, Broomfield, J.A, Pond, G, Caetano, S, Ellis, P.M, Greenspoon, J
Published in International journal of radiation oncology, biology, physics (01.11.2015)
Published in International journal of radiation oncology, biology, physics (01.11.2015)
Get full text
Journal Article
On the receiving end V: Patient perceptions of the side effects of cancer chemotherapy in 1993
Griffin, A. M., Butow, P. N., Coates, A. S., Childs, A. M., Ellis, P. M., Dunn, S. M., Tattersall, M. H. N.
Published in Annals of oncology (01.02.1996)
Published in Annals of oncology (01.02.1996)
Get full text
Journal Article
412 BMS-754807, an oral dual IGF-1R/insulin receptor (IR) inhibitor: initial results from a Phase 1 dose- and schedule-finding study in combination with carboplatin/paclitaxel in subjects with solid tumors
Chu, Q.S, Kim, S.W, Ellis, P.M, Mileshkin, L, de Boer, R.H, Park, J.S, Pellas, T, Huang, F, Finckenstein, F. Graf, Dhar, A
Published in European journal of cancer supplements (2010)
Published in European journal of cancer supplements (2010)
Get full text
Journal Article
114TiP KEYNOTE-B99: Phase II study of pembrolizumab plus investigational agents combined with chemotherapy as first-line therapy for extensive-stage small cell lung cancer (ES-SCLC)
Peled, N., Rodriguez-Abreu, D., Bordoni, R., Ellis, P.M., Hochmair, M., Müller, V., Levchenko, E., Zhou, H., Zhao, B., Lara-Guerra, H., Ahn, M-J.
Published in Annals of oncology (01.12.2021)
Published in Annals of oncology (01.12.2021)
Get full text
Journal Article
Cardiac Morbidity Following Chemoradiation in Stage III Non-small Cell Lung Cancer Patients: A Population-Based Cohort Study
Donovan, E.K., Pond, G.R., Seow, H., Ellis, P.M., Swaminath, A.
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.02.2023)
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.02.2023)
Get full text
Journal Article
Complementary medicine (CM) use in phase III clinical trials (P3T) conducted by the Canadian Cancer Trials Group (CCTG)
Wells, J.C., Sidhu, A., Ding, K., Heng, D.Y.C., Shepherd, F., Ellis, P.M., Bradbury, P.A., Jonker, D.J., Moore, M., Siu, L.L., Gelmon, K.A., Karapetis, C., Shapiro, J., Nott, L., O’Callaghan, C.J., Parulekar, W.R., Seymour, L.K., Smoragiewicz, M., Monzon, J.G.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
1758PD - Complementary medicine (CM) use in phase III clinical trials (P3T) conducted by the Canadian Cancer Trials Group (CCTG)
Wells, J.C., Sidhu, A., Ding, K., Heng, D.Y.C., Shepherd, F., Ellis, P.M., Bradbury, P.A., Jonker, D.J., Moore, M., Siu, L.L., Gelmon, K.A., Karapetis, C., Shapiro, J., Nott, L., O’Callaghan, C.J., Parulekar, W.R., Seymour, L.K., Smoragiewicz, M., Monzon, J.G.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
474P - Pharmacokinetic (PK) and updated survival data from the Canadian cancer trials group IND.226 study of durvalumab ± tremelimumab in combination with platinum-doublet chemotherapy
Hao, D., Ellis, P.M., Laurie, S.A., Juergens, R.A., Mates, M., Bradbury, P.A., Tsao, M., Tehfe, M., Kollmannsberger, C.K., Goffin, J.R., Wheatley-Price, P., Hilton, J., Robinson, A.G., Brown-Walker, P., Tu, D., Smoragiewicz, M., Seymour, L.K.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Pharmacokinetic (PK) and updated survival data from the Canadian cancer trials group IND.226 study of durvalumab ± tremelimumab in combination with platinum-doublet chemotherapy
Hao, D., Ellis, P.M., Laurie, S.A., Juergens, R.A., Mates, M., Bradbury, P.A., Tsao, M., Tehfe, M., Kollmannsberger, C.K., Goffin, J.R., Wheatley-Price, P., Hilton, J., Robinson, A.G., Brown-Walker, P., Tu, D., Smoragiewicz, M., Seymour, L.K.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Guideline for the Initial Management of Small Cell Lung Cancer (Limited and Extensive Stage) and the Role of Thoracic Radiotherapy and First-line Chemotherapy
Sun, A., Durocher-Allen, L.D., Ellis, P.M., Ung, Y.C., Goffin, J.R., Ramchandar, K., Darling, G.
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.10.2018)
Published in Clinical oncology (Royal College of Radiologists (Great Britain)) (01.10.2018)
Get full text
Journal Article
Initial management of small-cell lung cancer (limited- and extensive-stage) and the role of thoracic radiotherapy and first-line chemotherapy: a systematic review
Sun, A, Durocher-Allen, L D, Ellis, P M, Ung, Y C, Goffin, J R, Ramchandar, K, Darling, G
Published in Current oncology (Toronto) (01.06.2019)
Published in Current oncology (Toronto) (01.06.2019)
Get full text
Journal Article